Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
<p>Abstract</p> <p>Introduction</p> <p>Radioiodine (<sup>131</sup>I) therapy is widely accepted as an essential part of therapeutic regimens in many cases of differentiated thyroid cancer. Radiation-induced oxidative damage to macromolecules is a well known...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | Thyroid Research |
Online Access: | http://www.thyroidresearchjournal.com/content/3/1/7 |